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Abstract
The involvement of Cancer Stem Cells (CSCs) in tumor progression and tumor recurrence is one of the most studied subjects
in current cancer research. The CSC hypothesis states that cancer cell populations are characterized by a hierarchical
structure that affects cancer progression. Due to the complex dynamics involving CSCs and the other cancer cell
subpopulations, a robust theory explaining their action has not been established yet. Some indications can be obtained by
combining mathematical modeling and experimental data to understand tumor dynamics and to generate new
experimental hypotheses. Here, we present a model describing the initial phase of ErbB2+ mammary cancer progression,
which arises from a joint effort combing mathematical modeling and cancer biology. The proposed model represents a new
approach to investigate the CSC-driven tumorigenesis and to analyze the relations among crucial events involving cancer
cell subpopulations. Using in vivo and in vitro data we tuned the model to reproduce the initial dynamics of cancer growth,
and we used its solution to characterize observed cancer progression with respect to mutual CSC and progenitor cell
variation. The model was also used to investigate which association occurs among cell phenotypes when specific cell
markers are considered. Finally, we found various correlations among model parameters which cannot be directly inferred
from the available biological data and these dependencies were used to characterize the dynamics of cancer
subpopulations during the initial phase of ErbB2+ mammary cancer progression.
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Introduction
There is increasing evidence to support the theory that the
progression of many human tumors is controlled by a cellular
hierarchy in which Cancer Stem Cells (CSCs) constitute the core
of tumor mass. This hierarchical organization is due to CSC
properties, such as strong tumorigenic capacity, self-renewal, and
differentiation into non-stem cells [1]. Specifically, CSCs can
proliferate either symmetrically or asymmetrically. In the former
case two daughter cells with CSC features are generated, in the
latter one a multipotent Progenitor Cell (PC) and a CSC-like
daughter cell are produced. PCs proliferate giving rise to daughter
cells which are more differentiated and endowed with a lower
proliferative potential than their mother cells. Hence, this
mechanism leads to heterogeneous cancer subpopulations char-
acterized by a high degree of differentiation and a loss of
proliferation ability [2]. The CSC biology has been extensively
studied in the last few years [3–6] but it is not fully understood yet.
Many crucial issues are still under investigation, such as dynamics
related to the initial phase of tumor growth [7]. In this complex
context, experimental studies per se may be infeasible (both from
budget and time point of views) to investigate all possible
combinations of the crucial factors that regulate tumor onset
and development. Therefore, the contribution of mathematical
modeling in cancer biology can be useful in order to restrict the
number of wet-lab experiments needed for testing hypotheses and
for generating new conjectures. Indeed, the idea underlying the
definition and analysis of a model is to identify the macro events
characterizing the biological phenomena under study.
Several in-silico models describing cancer cell population
dynamics have contributed to an improved characterization of
tumor progression. In particular, Molina-Pena and A´lvarez built a
flexible deterministic model proving that there are some common
kinetic features of tumor growth among different cancers,
consistent with the CSC hypothesis [8]. Marciniak-Czochra’s
group has mathematically investigated the role of CSC symmet-
rical proliferation with respect to tumor maintenance and
published their results in several papers [9–11].
In other papers, the study of cell population dynamics in specific
tissues has been reported, emphasizing the role of CSC-based
organization in growth and regeneration processes. Johnston et al.
have characterized population dynamics in healthy crypts,
demonstrating that changing any of the key parameters can
initiate cancerogenesis [12,13]. Compartment models on colonic
crypts have also been proposed by Tomlinson et al [14,15] and by
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Mirams et al, the latter of which investigated how space influences
cell dynamics in colonic crypts [16].
Lander’s group studied the general process of tissue develop-
ment and regeneration, where impressive examples of tight control
of cell growth and differentiation can be found [17–21]. They
investigated also control mechanisms in tumor progression
showing that cancer growth is controlled by the spatio-temporal
dynamics of key signaling processes, expressed as positive and
negative feedback loops [22].
Lastly, Michor and coworkers have proposed several models
describing the tumor initiation and progression, starting from the
clonal evolution theory [23–26]. Their works contributed to the
characterization of the fundamental principles governing dynam-
ics of oncogene activation and tumor-suppressor inhibition [23].
The aim of our work is to study the tumorigenic capability of
CSCs using an integrated approach where a mathematical model
describing the initial phase of cancer progression has been
constructed and calibrated by exploiting data coming from in
vivo and in vitro experiments.
Even though it is well known that breast cancer is composed of
heterogeneous cancer cell subpopulations organized in a hierar-
chical manner, the dynamics regulating proliferation, death, and
differentiation of CSCs and progenies are difficult to infer from
tumor volume data alone.
Here, we present a study on ErbB2+ mammary cancer through
the synergistic union of wet-lab experiments and applied
mathematical techniques. We use CSC theory to define a system
of Ordinary Differential Equations (ODEs) describing the initial
phase of cancer progression. We refer to this model as essential in
order to focus the attention on its basic, but not simplistic form: it
provides a system abstraction which is relatively simple, but still
able to capture the key aspects of breast cancer. Moreover,
quantitative and qualitative analysis of this ODE system has been
performed to highlight the relations among proliferation, death,
and differentiation rates which cannot be directly inferred from
biological experiments.
This mathematical model has been elicited from several papers
describing CSC evolution [2,27,28], and from experimental
evidences [29]. Indeed, in [29] we have previously shown that
mammary cancers which spontaneously arise in BALB-neuT mice
- transgenic for the activated rat ErbB2 oncogene - contain a
population of CSCs able to generate mammospheres in vitro,
which are also endowed with the ability to initiate tumors in vivo.
In the same paper, we also reported that mammospheres obtained
from an epithelial cell line derived from a BALB-neuT carcinoma,
named TUBO cells, express markers associated with CSC
phenotype. Moreover, TUBO cells are able to efficiently generate
tumors when implanted subcutaneously (s.c.) into syngeneic mice
[30]. Summarizing, starting from an essential description of breast
cancer dynamics, we calibrated our model by considering several
experimental conditions, and we extrapolated relations among the
critical parameters hence inferring the rules which control the
initial cancer progression observed in mice. Moreover, we used the
model to investigate the distribution of known cell markers among
the various tumor cell populations, and to design new biological
experiments for the CSC characterization.
Material and Methods
Biological Experiments
Cell and mammosphere cultures. TUBO epithelial cells
(an ErbB2+ cloned cell line established from a mammary
carcinoma arising in a BALB-neuT female mouse [31,32]) were
cultured in DMEM supplemented with 20% FBS. To generate
non-adherent spherical clusters of cells (mammospheres), TUBO
cells were detached and plated in ultra-low attachment flasks
(Sigma-aldrich) at 66104 viable cells/ml in mammosphere
medium. This medium consists of serum-free DMEM-F12
medium (Invitrogen Corp.) supplemented with 20 ng/ml basic
Fibroblast Growth Factor (bFGF), 20 ng/ml Epidermal Growth
Factor (EGF), 5 microg/ml insulin, and 0.4% bovine serum
albumin (BSA) - all from Sigma-Aldrich [30]. Mammospheres
named P1 were collected after 7 days and disaggregated using
enzymatic and mechanical dissociation. P1-derived single-cell
suspensions were seeded again at 66104 viable cells/ml to
generate new mammospheres, named P2. The process was
repeated a third time to generate P3.
Mouse model. Female BALB/c mice (Charles River Labo-
ratories) were maintained at the Molecular Biotechnology Center
of the University of Torino and treated in accordance with the
University Ethical Committee and European guidelines. All in
vivo experiments were approved by the University of Torino
Ethical Committee and by the Italian Health Department (Rome,
Italy). TUBO (103 and 105) and P3 (103) cells were implanted s.c.
into the left flanks of BALB/c mice. Mice were killed according to
the ethic protocol when the average of the two perpendicular
diameters exceeded 10 mm. The growth of tumors related to these
three different initial conditions was monitored every week and
reported as average diameter (mm). Let us note that the three
initial conditions - in terms of cell types and concentrations - lead
to three sets of experiments that will be referred in the rest of this
paper using the notation exp1, exp2, and exp3.
FACS analysis. After 7 days of culture, TUBO, P1, P2, and
P3 cells were collected and disaggregated using enzymatic and
mechanical dissociation. Then they were washed in PBS (Sigma-
Aldrich) supplemented with 0.2% BSA and 0.01% sodium azide
(Sigma-Aldrich), and stained for membrane antigens. The
following antibodies were used: (i) Alexa Fluor647-conjugated
anti-Stem Cell Antigen-1 (Sca-1), (ii) PE-conjugated anti-CD44
and PE/Cy7-conjugated anti-CD24 (all from Biolegend). All
samples were collected and analyzed using a CyAn ADP Flow
Cytometer and Summit 4.3 software (DakoCytomation).
Mathematical approach
The above biological data were integrated in a mathematical
framework to reproduce the observed tumor growth and to infer
further knowledge on the relations occurring among the crucial
events involving cancer cell subpopulations. In detail, our
mathematical approach consists of the following main steps:
(i) tumor growth rates were estimated by fitting measured
volume data with the Malthusian model - Malthusian growth
model subsection;
(ii) volume growth and subpopulation dynamics were described
by a system of differential equations defined from the assumptions
of CSC theory - Breast cancer compartment model subsection;
(iii) the model solution was analytically evaluated to establish the
temporal evolutions of the system and to find the parameters
responsible for tumor progression - Model solution subsection;
(iv) an aggregation process was performed on model parameters
to define new parameters which refer to groups of similar cellular
events. This aggregation process resulted in a first reduction of the
parameter space. Some biological constraints were introduced to
make the model consistent with experimental data and properties
reported in the literature. This led to a further reduction of the
parameter space - Parameter settings subsection;
(v) volume data were fitted with the proposed model, from
which cell subpopulation dynamics were also derived. These
results, which turned out to be consistent with both the tumor
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growth data and the imposed properties, where then used as a
starting point for further analyses on model parameters. Specif-
ically, some hidden relationships among cellular events were
discovered, so that the role of CSCs in cancer progression was
better characterized - Data fitting subsection.
Technical details about each of these steps are reported in the
following sections and in Supplementary Material.
Malthusian growth model. Tumor growth can be conve-
niently described by means of the Malthusian model [33]
assuming that there are no nutrient transport limitations and that
space constraints are not significant. The Malthusian growth
model, also called the power-law model, describes an exponential
growth based on a constant rate bi through the equation:
V ’(t)~biV (t), ð1Þ
where i = exp1, exp2, and exp3; see the Mice model subsection.
Note that this assumption is reasonable since the hypothesis that
cancer volume V(t) increases with a constant cellular growth rate is
mostly acceptable during its initial progression phase.
Breast cancer compartment model. Even though the
Malthusian growth model gives a good representation of the
overall tumor growth, it is not able to directly capture relationships
among different cancer cell subpopulations. Thus, to point out
which are the key factors in tumor progression, we represented cell
subpopulation dynamics using the following system of linear
ODEs:
dNCSC
dt
~PsyvCSCNCSCzcPCNPC1{g1NCSC{d1NCSC
dNPC1
dt
~(1{Psy)vCSCNCSC{vPCNPC1{cPCNPC1
zg1NCSC{g2NPC1{d2NPC1
dNPC2
dt
~2vPCNPC1zg2NPC1{g3NPC2{d2NPC2
dNTC
dt
~g3NPC2{d3NTC , ð2Þ
where NCSC , NPC1 , NPC2 , NTC are the numbers of CSCs, PCs1,
PCs2, TCs, respectively.
This system was designed taking inspiration from the model
reported in the work [27] and then integrated with knowledge
about cancer dynamics derived from several papers, among which
[2,8,34]. Our model takes into account the self-renewing ability of
CSCs that can be symmetrical (PsyvCSC ) or asymmetrical
((1{Psy)vCSC ). Moreover, a progression of CSCs - called CSC
commitment (g1) - can occur in terms of differentiation when a
CSC gives rise to a multi-potent PC. Equations in (2) model two
layers of PC subpopulations: PCs1 and PCs2. The first one is
characterized by proliferation and differentiation capabilities that
are both involved into the progression of PCs2 which develop into
non-proliferative Terminally differentiated Cells (TCs). We
considered also the de-differentiation (cPC ) of PCs1 into CSCs,
as described in [35] and mathematically characterized in [36].
Lastly, cancer stem, progenitors and differentiated cells are
affected by a death rate (d) specific for each cell type.
The system of ODEs represented by Equations (2), augmented
with the following set of initial conditions
NCSC(0)~N
0
CSC , NPC(0)~N
0
PC , NTC(0)~N
0
TC , ð3Þ
constitutes a Cauchy problem which describes the temporal
evolution of breast cancer, with a focus on its different cell
subpopulations.
Model solution. It is well known that a Cauchy problem of
the type represented by Equations (2) and (3) can be analytically
solved to obtain the size of each cell subpopulation at any time
point [37]. Specifically, the model solution is derived from the
model eigensystem which determines the temporal evolution of the
system and its stability as well [37]. In particular, among all these
eigenvalues, there is one called growth constant (ls~l4) which
defines the system growth rate; its corresponding eigenvector (Ws)
defines the system growth direction.
To explore model (2) from different perspectives, we have
performed a set of qualitative and quantitative analyses. Results
coming from these two analyses are complementary, and
contribute to obtain a global and complete understanding of the
model. More details on the model solution and on how the model
eigensystem controls the system behavior are provided in
Equations (s.3) of Supplementary Material.
Parameter settings. Parameter aggregation. The model
described by system (2) comprises four independent variables, i.e.
one for each cell subpopulation, and ten parameters defining cell
dynamics. More precisely, each parameter describes a specific
cellular event (proliferation, differentiation,…) and it is indepen-
dent of the others. This high specificity provides a complete
description of the subpopulation dynamics, but it requires a high
number of parameters difficult to estimate. To cope with this, we
have defined a new set of aggregated parameters grouping the
original kinetic parameters as follows:
(i) a~ {g1zPsyvCSC{d1
(ii) b~ g1z(1{Psy)vCSC
(iii) c~ d2zg2zcPCzvPC
(iv) d~ g2z2vPC
(v) e~ d2zg3:
ð4Þ
This aggregating process provided new parameters describing
the flow of each cell subpopulations in the model. The meaning of
these new parameters can be explained by the following biological
interpretation: (i) a expresses CSC variation, neglecting the de-
differentiation term cPC ; (ii) b describes the increasing rate of PCs1;
(iii) c represents the PC1 decreasing rate; (iv) d is the increasing rate
of PCs2; and (v) e is the decreasing rate of PCs2. Let us note that
this aggregation has been a crucial step of the analysis process for
several reasons. It decreased the complexity of the ODE system
reducing the dimension of the parameter space, and it made
equations easier to manage. Using the aggregate parameters (4) in
system (2), we decrease the number of parameters that must be
inferred from experimental data, being a, b, c, d, e, cPC , g3, and d3
the only ones that had to be estimated. Moreover, from equations
(4), it is clear that all aggregate parameters are positive except a,
whose sign depends on the balance among CSC symmetrical
proliferation, differentiation, and death rate.
Parameter space is restricted by biological
constraints. To make the model behavior consistent with the
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biological phenomenon under investigation, we imposed a set of
constraints on the parameter values. Part of them are related to
biological knowledge on breast cancer growth, while others derive
from our experimental data. From the evaluation of tumor growth
in BALB/c mice we used the Malthusian model as a first
approximation of cancer progression which allowed to estimate
the experimental growth rates bi (with i= exp1, exp2, exp3) from
the available data. Then, the growth rate ls in the linear ODE
system was set equal to bi. The progenitor and terminal
subpopulations represent the majority of cancer cells [28];
however, the proportion of all subpopulations should be deter-
mined by the type and number of cells injected in the mice. From
our experiments we deduced that P3 cells are more enriched in
CSCs than TUBO cells. In particular, the analysis of Sca-1+ and
CD44+/CD242 cells revealed the CSC amount in each mammo-
spheres passages.
During the ‘‘exponential growth phase’’ the ratios between the
subpopulation sizes and total cell number (NTOT) are functions of
time which became practically constant as the time parameter
grows large [38–40]. Therefore, we imposed the following
conditions on the cell subpopulation fractions:
NCSC
NTOT
~k
½i
CSC ,
NPC
NTOT
~k
½i
PC ,
NTC
NTOT
~k
½i
TC~1{(k
½i
CSCzk
½i
PC), ð5Þ
where i= exp1, exp2, exp3 to reproduce each type of cell injection.
Note that, knowing the analytic solution of model (2), above
conditions (5) can be easily expressed using system eigenvectors, as
reported in Supplementary Material - Equations (s.7).
At last, Tang [2] describes the de-differentiation as a rare event
since it occurs only under particular conditions, the variation
interval of cPC - defined in the data fitting process - was chosen
smaller than those of the other parameters.
To conclude, taking into consideration all previous constraints,
the number of free parameters was reduced and the parameter
space was downsized since a,d,d3 and g3 were directly inferred
from experimental data, while b, c, e and cPC had to be computed
considering all their possible positive values.
Data fitting. System (2) describes how the total number of
breast cancer cells - and the corresponding tumor volume - change
during time. Assuming that each spherical shaped cell gives the
same contribution to the spherical tumor, we stated that a tumor
grows proportionally to the total number NTOT of cells.
Numerically, we had V (mm3)~k1|4:18|10
{6|NTOT (t),
where k1 is a volume-growth constant, which accounts for the
percentage of quiescent/dead cells in tumor, i.e. a new parameter.
The parameter space was explored using the standard
Minimum Least Square (MLS) technique to produce the best fit
of breast cancer data. This method searches the parameter
combination that minimizes the sum of squared residuals. Note
that the MLS algorithm searches the optimal solution, within the
parameters space, starting from a set of fixed values
p0~½k01,b0,c0,e0,c0PC . To find the best data fitting, we run the
MLS method several times, using different initial parameter
choices. These starting values were defined through the latin
hypercube sampling technique [41] using the following distribu-
tions: (i) c0PC* Unif (0,0:1); (ii) fb0,c0,e0g* Unif (0, 5). The
variation intervals were chosen in accordance with the literature
and the range of cPC was set smaller than that of other parameters
as mentioned before. Finally, let us point out that there are several
types of distributions that can be used as probability density
functions to define the starting points of the method. This choice
should depend on a priori information but, when no data are
available, the natural assumption is the uniform distribution.
Results
Cancer growth model
The in vitro experiments generated three passages of mammo-
spheres enriched in CSCs starting from a single cell suspension of
TUBO cells. In detail, floating spherical mammospheres devel-
oped (P1) after a 2 day culture and became symmetrically
encapsulated after 7 days to form golf ball-like structures that
afterward got to be hollow inside around the third week and did
not grow or expand further. These P1 mammospheres were
dissociated after a culture of 7 days and propagated in secondary
(P2) and tertiary (P3) sphere passages. Clones generated from
TUBO, P1, P2 and P3 cells were counted in order to weigh up the
in vitro self-renewal potential of mammospheres. To determine
the tumorigenic potential of mammospheres with respect to
TUBO cells, we selected three initial cell concentrations: 105
TUBO, 103 TUBO, 103 P3 cells, and we implanted them s.c. in
syngeneic BALB/c mice. Injection of 103 P3-derived cells gave rise
to fast growing tumors in all mice, whereas a similar challenge of
103 TUBO cells gave rise to tumors in 4 out of 6 mice, but only
two tumors reached a 10 mm average diameter in the following
100 days. In detail, the percentage of tumor takes in mice injected
with 105 TUBO or 103 P3-derived cells was 100%, while this value
decreased to 67% in mice injected with 103 TUBO cells. Let us
note that for further analysis we considered only those mice in
which cancer grew exponentially, see Table S1. The higher
propensity to form breast cancer in 60 days of 105 TUBO cells and
103 P3 with respect to 103 TUBO cells can be appreciated in
Figure 1 (panel a).
The Malthusian model (1) was fit to measured cancer growth
data to determine the bulk growth parameters (bi) for each cancer
scenario - i.e. 103, 105 TUBO cells, and 103 P3-derived cells.
Figure 1. Tumors growth data and stem cell markers expression. Panel (a): tumor onset ability of 105 TUBO cells (violet points), 103 TUBO
cells (orange points) and 103 P3-derived cells (blue), injected in mice. Panel (b): Sca-1+ and CD44+/CD242 histograms reporting the mean 6 SEM of
positive cells, from six independent experiments. *p,0.1, **p,0.05, Wilcoxon test.
doi:10.1371/journal.pone.0106193.g001
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Moreover, these numerical growth rate estimations confirmed the
experimental evidence that P3 cells have a larger tumorigenic
potential than any concentration of TUBO cells, when injected in
mice. Indeed, in 103 TUBO scenario bi is equal to 0.06, in 10
5
TUBO scenario bi is equal to 0.07, and in 10
3 P3 scenario bi is
equal to 0.09. The model curve-fit provided by the Malthusian
model is reported in Figure S1. As we already observed, even
though this model accurately describes cancer growth in terms of
volume expansion, it does not characterize the relations among
cancer cell subpopulations.
We inferred CSC, PC and TC behaviors by means of the
essential model (2) that includes the cell subpopulation distribu-
tions in tumor mass starting from the assumptions of CSC theory.
Then, we tuned the aggregated parameters using the biological
constrains, described in Material and Methods, combined with the
experimental values of breast cancer volumes and the proportion
of CSCs derived from the percentage of Sca-1+ and CD44+/
CD242 cells. A FACS analysis of stem cell markers showed that
Sca-1 [30] is barely expressed on TUBO cells while its expression
progressively increases from P1 to P3-derived cells. The CSC
enrichment in mammosphere passages was further confirmed by
the progressive increase of CD44+/CD242 cells observed from
TUBO to P3 mammospheres, as reported in Figure 1 (panel b).
For each initial condition, we performed a number of MLS runs
greater than 10 and, among the results provided by these runs, we
selected the best-fit which minimizes the sum of squared residuals.
Notice that different initial conditions were determined by the type
and number of cell injected (exp1, exp2, exp3) and by the stem
marker used to quantify CSC proportion (Sca-1+ or CD44+/
CD242). The best-fit parameters estimated for each of these initial
conditions are reported in Table 1, while Figure 2 shows obtained
fits. The same volume-data (i.e. those of Figure 1, panel A) were
fitted by the model when either Sca-1+ or CD44+/CD242
proportions were assumed to infer CSC percentage within the
tumor mass. More precisely, the volume-data arising from the
same cell injection (exp1, exp2, exp3) were used twice: one for each
marker considered. Specifically, in Figure 2, panels a, b, c show
the model curve-fitting for each initial cell concentration,
considering cell subpopulation proportions extrapolated from
Sca-1+ data; while panels d, e, f show the model fitting when
cell proportions are obtained considering CD44+/CD242 cells. As
reported by Figure 2, the different fitting curves were equivalent in
terms of the produced error. However, subpopulation dynamics
changed when different proportions were assumed as shown by
Figure S2 for the injection of 103 TUBO cells.
How CSCs (mathematically) affect the tumor growth
Temporal evolutions predicted by the essential model were
analytically determined studying its eigensystem. Specifically, in
Material and Methods and Supplementary Material we pointed
out how the growth constant (ls) and its correspondent
eigenvector (Ws) can be used to determine the system growth
rate and direction. Explicit expressions of eigenvectors, as well as a
discussion on their signs (see Figure S3), are reported in
Supplementary Material. Summarizing, from this study we found
that the stability of system (2) is controlled by the eigenvector
ls~l4.
To biologically characterize this result, we have defined the
reproduction rate R0 of CSCs as their variation rate due to intra-
CSC mechanisms plus the rate of PCs1 which undergo de-
differentiation, namely R0~az
b
c
cPC . Therefore, the equilibrium
conditions can be expressed as:T
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l4 is
(i) negative{tumor extinction if R0v0,
(ii) null{tumor stability if R0~0,
(iii) positive{tumor growth if R0v0,
8><
>:
ð6Þ
similarly to epidemiological studies [42]. Notice that this result is in
line with the current knowledge on the kinetic of CSC-based
models which point out the role of CSC and PC1 as tumor driving
force [9,12,43], considering also cell migration as reported in
[44,45]. Indeed, Equations (6) emphasize how three possible
tumor-scenarios depend only on CSC reproduction rate, thus
remarking the central role of these cells in tumor progression. In
particular: if (i) is satisfied, the system moves toward extinction
(asymptotic stability), i.e. there is no tumor establishment; when
condition (ii) occurs, the model reaches a steady state, i.e. tumor
grows until it stabilizes to a plateau (cell homeostasis); while when
(iii) is met, the system grows exponentially, i.e. there is an
unbounded tumor growth. Let us note that the trivial steady state
(i.e. cell homeostasis) is very sensitive to small changes in combined
CSC and PC1 variation rates, since it occurs only when R0 = 0. On
the other hand, cell exponential growth (R0.0) and tumor
extinction (R0,0) are more robust with respect to such variations.
Therefore, despite this structural instability typical of linear
systems, we opted for a linear model able to well reproduce the
tumor exponential growth observed in mice. Indeed, at this stage
of our study, we were interested in describing breast cancer growth
during its initial exponential phase.
Lastly, being l4 defined in terms of the disaggregated
parameters (see Equation (s.5)) it is possible to derive a new set
of inequalities related to those of Equations (6). Note that CSC
symmetrical proliferation probability (Psy) expresses the variability
in CSC division regulating the system stochasticity; indeed,
different system behaviors can arise varying Psy. To quantify the
threshold associated with these behaviors, we solved the inequal-
ities (6) with respect to Psy and we grouped all other terms in the
new variable a. Specifically, solving systems (4) and (6) we
obtained the following set of relations:
l4 is
(i) negative if Psyva,
(ii) null if Psy~a
,
(iii) positive if Psywa,
8><
>:
ð7Þ
which agree with the well-known central role of CSC symmetrical
proliferation in cancer evolution [11]. The threshold a, whose
complete expression is
a~
(d1zg1)(d2zg2zvPC)zcPC(d1{vCSC)
vCSC(d2zg2zvPC)
, ð8Þ
represents a critical value which discriminates among possible
tumor evolutionary-scenarios, as shown in Figure 3. a involves
Figure 3. Three possible tumor scenarios. Each panel shows a possible system behavior: (a) Psyva , corresponding to extinction; (b) Psy~a,
population move towards steady state; (c) Psywa , population grow exponentially.
doi:10.1371/journal.pone.0106193.g003
Figure 2. The breast cancer compartment model fittings. Each panel reports a comparison between experimental volumes (points) and the
best model-fits (lines), considering a specific cell injection (105 TUBO, 103 TUBO or 103 P3) and a fixed CSC concentration (given by Sca-1+ or CD44+/
CD242 cells). In detail: panels (a), (b), (c) use Sca-1+ proportions and correspond to 105 TUBO, 103 TUBO and 103 P3 cells injections, respectively. On
the other hand, in panels (d), (e), (f) are reported results obtained from 105 TUBO, 103 TUBO and 103 P3 cells injections, using cells proportions defined
by CD44+/CD242 cells. For each plot, model parameters are those reported in Table 1.
doi:10.1371/journal.pone.0106193.g002
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many parameters, suggesting that tumor evolution can be
influenced acting on many of these parameters, i.e., on many of
their corresponding cellular events.
Discovering relationships among parameters
To extrapolate the relations among original model parameters,
the computed best fit-values (Table 1) were assigned to aggregated
parameters in system (4). Then, from this set of explicit equations,
some dependencies among the original parameters were deduced.
More precisely, Figure 4 (panel a) shows how the CSC prolifer-
ation rate (vCSC ) changes with respect to the CSC death rate (d1).
We also observed a linear relationship among the following
parameters: CSC differentiation (g1), CSC death (d1), and CSC
symmetrical proliferation probability (Psy), see Figure S4. We may
thus assume that there is a trade-off between the transformation/
death of CSCs and their proliferation.
We were also interested in discovering hidden relationships
among the aggregated parameters. Therefore, a regression analysis
was performed on all tuples of values generated by the MLS
algorithm and reported in Tables S2–S7 (more details are also
provided in Text S1). This analysis emphasized the linear
correlations between b2c and e2d, shown in Figure 4 (panels b,
c). For both correlations, the fitted linear regression models
reporting all parameter values are shown in Figure S5. It is
possible to observe that the decreasing rate of PC1 (c) is
proportional to the PC1 increasing rate (b) and a similar behavior
exists also between the decreasing (e) and increasing (d) rates of
PCs2. Let us note that, when we considered Sca-1
+ cells obtained
by in vitro experiments to compute CSC proportions, all these
correlations resulted independent of the three experimental
scenarios. On the other hand, when CD44+/CD242 cells were
used, these relations were extrapolated only for 103 P3 experi-
ments. Lastly, linear correlations b2a and c{c were derived in all
three experimental scenarios considering CD44+/CD242 propor-
tions, see Figure 4 (panels e, f). It is interesting to notice that the
increasing rate of PC1 (b) is correlated with respect to CSC
variation (a), as well as the PC1 decreasing rate (c) is correlated
with de-differentiation rate (cPC ) of PCs1. The fitted linear
regression models with all estimated parameter values are reported
in Figure S6.
Discussion
In this paper we provided an example of how a mathematical
model can help to understand a biological phenomenon and to
address biological hypotheses. We explored the initial phase of
ErbB2+ mammary cancer progression in mice focusing on two
aspects. First, we investigated the tumorigenic power of the TUBO
cell line and of successive mammosphere passages characterizing
mechanisms at the basis of tumor progression. Secondly, we
performed an accurate analysis on the dependencies among
parameters to identify which is the parameter(s) critical to
determine an exponential cancer growth. As a consequence, we
Figure 4. Linear dependencies among parameters. The CSC proliferation rate, vCSC , and the CSC death rate, d1 , have a mutual linear
dependence. Specifically, during initial steps of tumor progression, CSC proliferation is faster than CSC death. Panels (a), (d) show this relationship in
the Sca-1+ and CD44+/CD242 cells scenarios respectively. Other linear dependencies exist among parameters, in both scenarios. Panel (b): the PC1
decreasing rate, c, is linearly proportional to the PC1 increasing rate, b. Panel (c): linear dependence of the PC2 increasing rate, e, with respect to their
decreasing rate, d. Panel (e): liner relationship between the CSC global variation rate, a, and the PC1 increasing rate, b. Panel (f): how the PC1
decreasing rate, c, is affected by their de-differentiation rate, c. Notice that these linear relationships are valid in all the three injection scenarios.
Indeed, parameters show the same qualitative behavior in each panel, independently of their initial conditions.
doi:10.1371/journal.pone.0106193.g004
Table 2. Linear parameter dependencies.
Linear dependencies
Sca-1+ cells b2c (PC1)
*; e2d (PC2)
*
CD44+/CD242 cells b2a; c{c (CSC)*
Recapitulation of some hidden relationships among parameters have been extracted using data collected in the fitting process through regression analysis.
doi:10.1371/journal.pone.0106193.t002
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were able to detect key points in tumor progression that, if altered,
can change cancer evolution.
We presented an essential model describing the initial phase of
breast cancer growth and which gave us the opportunity to
reproduce growth volume data obtained from in vivo experiments.
Among these in vivo experiments we selected those corresponding
to mice in which the mammary cancer grew exponentially, and we
were able to produce a good fit for each initial condition.
However, we want to emphasize that our mathematical model can
mimic different cancer dynamics. Indeed, the previous analysis of
system (2) has revealed how CSCs (mathematically) affect tumor
growth since reproduction rate R0 gives rise to distinct tumor
scenarios: exponential cancer growth and tumor extinction. Cell
homeostasis will be guaranteed by introducing a feedback
mechanism which can maintain a stable equilibrium within tumor
cell subpopulations. These scenarios can be investigated in order
to identify which are the cellular events that can be perturbed in
vitro by treatments designed to influence cancer growth. For this
purpose, using our model it is possible to investigate at a
population level a fine-tuning of model parameters which leads
cancer into an extinction condition. An encouraging example of
how a computational model combined with experimental data can
help to verify how the therapy response influences cell population
dynamics is reported in a recent paper by Tyson et al. [46]. The
authors have showed that erlotinib - an epidermal growth factor
receptor inhibitor - is not able to kill tumor cells, but it leads them
into a quiescent state or decreases their proliferation rate.
Therefore, expressions (6) of possible system behaviors as
mathematical equations can give us the possibility to explore both
how different drugs work and against which targets, in term of cell
events, therapies must be addressed. Note that we further
investigated those parameter combinations (best-fit parameters)
where CSC reproduction rate (R0) is positive, as reported in
Table 1.
Previous papers report the crucial role of CSCs to cancer
progression [47,48], but a connection among some of CSC
features, i.e. strong self-renewal, resistance to apoptosis, differen-
tiation abilities, and cancer progression, has not been established.
Our results suggested which of these features mostly determine
cancer growth dynamics, namely those responsible for global CSC
and PC variation. Moreover, analyzing parameter values obtained
from all runs of the MLS algorithm we discovered some interesting
linear correlations among CSC differentiation, CSC death, and
CSC symmetrical proliferation probability. This is in accordance
with what is observed in many solid tumors or mammosphere
models, in which both intrinsic and extrinsic mechanisms known
to directly affect CSC symmetric division probability and
differentiation or apoptotis have been discovered. These mecha-
nisms, which include p53 mutation or depletion in CSCs [49], and
the availability of certain host growth factors - such as EGF and
growth-factor-rich niches - can skew division modes in favor of
symmetric production of CSCs for up to 85% [50]. Correlations
among other parameters were also reported emphasizing a
balance among all actions that generate or remove cells within
the same subpopulation. In particular, when we imposed cell
proportions obtained considering Sca-1+ data, these relations were
observed in PC1 and PC2 subpopulations. Otherwise, using data
obtained from CD44+/CD242 experiments, the trade-off was
observed in CSCs. This behavior explains the coexistence of
CSCs, PCs, and differentiated cells in the same tumor which, in
turn, reflects the cancer heterogeneity that could result from the
various differentiation grades of genetically identical cells.
While many markers of CSCs have been described in solid
tumors, no specific markers of PCs have been identified yet, and it
is probably more accurate to say that a tumor possesses a
continuous spectrum of cell types, ranging from CSCs to more
differentiated cells [8]. Indeed, the different correlations among
parameters that we obtained could be also explained by the fact
that, at present time, CSC’s markers are specific for the stemness
characteristic. Since the identification and characterization of
CSC markers is difficult, CSC marker cocktails might be more
representative of the cancer stem cell biological properties. From
our investigations, different linear correlations among parameters
have been discovered when different markers have been consid-
ered to infer subpopulation proportions. In detail, as summarized
in Table 2, it is interesting to note that dependencies involving PC
variations are mainly associated with Sca-1 experiments, while
correlations on CSC variations have been found considering
CD44+/CD242 cells.
The model could indicate an association of Sca-1+ phenotype
with progenitor cells and a connection of CD44+/CD242
phenotype with CSCs. These suggestions were considered and
preliminarily verified analyzing the percentages of Sca-1+/
CD44+/CD242 cells in all mammosphere passages by FACS
analysis. Figure 5 reports a comparison among the percentage of
Sca-1+, CD44+/CD242, and Sca-1+/CD44+/CD242 cells, in the
mammosphere passages. As expected, the amount of CD44+/
CD242 cells increases. Furthermore, the number of Sca-1+ cells is
larger than that with CD44+/CD242 phenotype. Finally, we
found that there is a constant number of Sca-1+ cells that are also
CD44+/CD242. These in vitro experiments provided a prelim-
inary evidence that a minimal portion of Sca-1+ cells is also
CD44+/CD242, yielding a first indication that Sca-1+ cells might
be a marker of PCs. Further investigations will be required to
Figure 5. Comparison among markers expression. Sca-1+, CD44+/CD242 and percentage of Sca-1+ positive that are CD44+/CD242 histograms
reporting the mean 6 SEM of positive cells, from six independent experiments.
doi:10.1371/journal.pone.0106193.g005
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understand if CD44+/CD242 phenotype will be lost in Sca-1+
cells, as a consequence of the differentiation process of precursor
cells. An in-silico validation will be produced fitting volume data
using the percentages of CD44+/CD242 and Sca-1+ cells to
indicate the initial concentrations of CSCs and PCs, respectively.
All dynamics considered in our model are related to how cell
population vary and cancer progression has been connected to
crucial cellular events, as CSC proliferation. Obviously, a deeper
characterization of specific cellular events during tumor progres-
sion might require the integration of molecular aspects in model.
However, we believe that results presented in this paper can be
used to facilitate and improve this integration. Hence, in a future
work we will combine these results with those of our recent paper
[51], in which ErbB2-driven carcinogenesis is described with a
multi-level model based on both molecular aspects and cell
subpopulation dynamics.
Supporting Information
Figure S1 Malthus model fittings. Each panel considers one
of the three initial cell concentrations, and reports a comparison
between experimental volumes (points) and the Malthus fit (solid
lines). In detail: panel A corresponds to the 105 TUBO cells
injection; panel B is related to the 103 TUBO cells experiments,
while panel C shows results about the 103 P3 cells case. The
quantitative estimation of the growth rates, b, is reported for each
case, highlighting the greater tumorigenic potential of P3 cells.
(TIFF)
Figure S2 Subpopulations dynamics and cellular pro-
portions, 103 TUBO cells. Temporal evolutions of cells
subpopulations, panel A, and their proportions in the total tumor
mass, panel B, considering the percentage of Sca-1+ cells.
Temporal evolutions of cells subpopulations, panel C, and their
proportions in the total tumor mass, panel D, considering the
percentage of CD44+/CD242 cells. Once the best-set of
parameters is defined, these results are directly derived from the
model solution.
(TIFF)
Figure S3 Possible signs of l4 eigenvalue. Mutual position
in the plane of line F(x) and: parabola G(x), panel A; parabola 2
G(x), panel B.
(TIFF)
Figure S4 CSCs symmetrical proliferation probability.
In the initial cancer growth phase, the CSCs symmetrical
probability (Psy) expresses a fixed behavior with respect to the
CSCs differentiation (g1), and the CSCs death (d1). Each panel
shows this mutual relationship, considering one of the three initial
condition experiments, and one of the two CSCs proportions. In
detail: panels A, B and C correspond to the Sca-1+ marker
scenario having 105 TUBO, 103 TUBO and 103 P3 cells,
respectively. On the other side, panels D, E and F are relative to
the CD44+/CD242 case with 105 TUBO, 103 TUBO and 103 P3
cells injection, respectively.
(TIFF)
Figure S5 Linear regressions among reduced parame-
ters in the Sca-1+ marker proportions scenario. Correla-
tion analysis among parameters-values (obtained from the MLS
algorithm) highlights a strong linear correlation between pairs b2c
and e2d. In each plot scattered parameters values are compared
with the corresponding regression line, and the relative correlation
coefficient is also reported. Each panel corresponds to correlations
between the two pairs, considering one of the three initial
conditions. Specifically, reading panels by columns it is possible to
observe results with respect to the different initial conditions:
panels A and D correspond to 105 TUBO cells; panels B and E are
relative to 103 TUBO cells; while panels C and F match the 103 P3
cells case. Otherwise, reading panels by rows, results are presented
considering the parameters-pairs: panels A, B and C are relative to
b2c; while panels D, E and F show e2d results.
(TIFF)
Figure S6 Linear regressions among reduced parame-
ters, in the CD44+/CD242marker proportions scenario.
Correlation analysis among parameters-values (obtained from the
MLS algorithm) highlights a strong linear correlation between
pairs b2a and c{c. In each plot scattered parameters values are
compared with the corresponding regression line, and the relative
correlation coefficient is also reported. Each panel corresponds to
correlations between the two pairs, considering one of the three
initial conditions. Specifically, reading panels by columns it is
possible to observe results with respect to the different initial
conditions: panels A and D correspond to 105 TUBO cells; panels
B and E are relative to 103 TUBO cells; while panels C and F
match the 103 P3 cells case. Otherwise, reading panels by rows,
results are presented considering the parameter-pairs: panels A, B
and C are relative to b2a, while panels D, E and F show c{c
results.
(TIFF)
Table S1 Tumor volume data. Tumor growth, evaluated as
tumor mean diameter (in mm), measured over time in mice
injected with 105 TUBO (upper part), 103 TUBO (middle part),
and 103 P3 cells (lower part).
(PDF)
Table S2 Parameters estimation experiments, 105
TUBO cell injection, Sca-1+ proportions. Normalized
parameter-values obtained by several runs of the Minimum Least
Square algorithm. Within each set of experiments, best fit
parameters are highlighted with bold characters. Normalization
vectors are reported in Text S1.
(PDF)
Table S3 Parameters estimation experiments, 103
TUBO cell injection, Sca-1+ proportions. Normalized
parameter-values obtained by several runs of the Minimum Least
Square algorithm. Within each set of experiments, best fit
parameters are highlighted with bold characters. Normalization
vectors are reported in Text S1.
(PDF)
Table S4 Parameters estimation experiments, 103 P3
cells injection, Sca-1+ proportions. Normalized parameter-
values obtained by several runs of the Minimum Least Square
algorithm. Within each set of experiments, best fit parameters are
highlighted with bold characters. Normalization vectors are
reported in Text S1.
(PDF)
Table S5 Parameters estimation experiments, 105
TUBO cells, CD44+/CD242 proportions. Normalized
parameter-values obtained by several runs of the Minimum Least
Square algorithm. Within each set of experiments, best fit
parameters are highlighted with bold characters. Normalization
vectors are reported in Text S1.
(PDF)
Table S6 Parameters estimation experiments, 103
TUBO cells, CD44+/CD242 proportions. Normalized
parameter-values obtained by several runs of the Minimum Least
Square algorithm. Within each set of experiments, best fit
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parameters are highlighted with bold characters. Normalization
vectors are reported in Text S1.
(PDF)
Table S7 Parameters estimation experiments, 103 P3
cells, CD44+/CD242 proportions. Normalized parameter-
values obtained by several runs of the Minimum Least Square
algorithm. Within each set of experiments, best fit parameters are
highlighted with bold characters. Normalization vectors are
reported in Text S1.
(PDF)
Text S1 Mathematical analysis. Description of the mathe-
matical model and its solution; analysis of model eigensystem;
results of parameter estimation.
(PDF)
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